797 related articles for article (PubMed ID: 30639256)
1. Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications.
Dadfar SM; Roemhild K; Drude NI; von Stillfried S; Knüchel R; Kiessling F; Lammers T
Adv Drug Deliv Rev; 2019 Jan; 138():302-325. PubMed ID: 30639256
[TBL] [Abstract][Full Text] [Related]
2. Advances in Atherosclerosis Theranostics Harnessing Iron Oxide-Based Nanoparticles.
Wang S; He H; Mao Y; Zhang Y; Gu N
Adv Sci (Weinh); 2024 May; 11(17):e2308298. PubMed ID: 38368274
[TBL] [Abstract][Full Text] [Related]
3. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Zhu L; Zhou Z; Mao H; Yang L
Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
[TBL] [Abstract][Full Text] [Related]
4. Surface engineering of iron oxide nanoparticles for targeted cancer therapy.
Kievit FM; Zhang M
Acc Chem Res; 2011 Oct; 44(10):853-62. PubMed ID: 21528865
[TBL] [Abstract][Full Text] [Related]
5. Size-isolation of superparamagnetic iron oxide nanoparticles improves MRI, MPI and hyperthermia performance.
Dadfar SM; Camozzi D; Darguzyte M; Roemhild K; Varvarà P; Metselaar J; Banala S; Straub M; Güvener N; Engelmann U; Slabu I; Buhl M; van Leusen J; Kögerler P; Hermanns-Sachweh B; Schulz V; Kiessling F; Lammers T
J Nanobiotechnology; 2020 Jan; 18(1):22. PubMed ID: 31992302
[TBL] [Abstract][Full Text] [Related]
6. Chemical synthesis and assembly of uniformly sized iron oxide nanoparticles for medical applications.
Ling D; Lee N; Hyeon T
Acc Chem Res; 2015 May; 48(5):1276-85. PubMed ID: 25922976
[TBL] [Abstract][Full Text] [Related]
7. Magnetic iron oxide nanoparticles as drug carriers: preparation, conjugation and delivery.
El-Boubbou K
Nanomedicine (Lond); 2018 Apr; 13(8):929-952. PubMed ID: 29546817
[TBL] [Abstract][Full Text] [Related]
8. Next-generation superparamagnetic iron oxide nanoparticles for cancer theranostics.
Li K; Nejadnik H; Daldrup-Link HE
Drug Discov Today; 2017 Sep; 22(9):1421-1429. PubMed ID: 28454771
[TBL] [Abstract][Full Text] [Related]
9. Construction of iron oxide nanoparticle-based hybrid platforms for tumor imaging and therapy.
Hu Y; Mignani S; Majoral JP; Shen M; Shi X
Chem Soc Rev; 2018 Mar; 47(5):1874-1900. PubMed ID: 29376542
[TBL] [Abstract][Full Text] [Related]
10. Optimization and Design of Magnetic Ferrite Nanoparticles with Uniform Tumor Distribution for Highly Sensitive MRI/MPI Performance and Improved Magnetic Hyperthermia Therapy.
Du Y; Liu X; Liang Q; Liang XJ; Tian J
Nano Lett; 2019 Jun; 19(6):3618-3626. PubMed ID: 31074627
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
Kandasamy G; Maity D
Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
[TBL] [Abstract][Full Text] [Related]
12. Shape-, size- and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranostics.
Xie W; Guo Z; Gao F; Gao Q; Wang D; Liaw BS; Cai Q; Sun X; Wang X; Zhao L
Theranostics; 2018; 8(12):3284-3307. PubMed ID: 29930730
[TBL] [Abstract][Full Text] [Related]
13. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications.
Gupta AK; Naregalkar RR; Vaidya VD; Gupta M
Nanomedicine (Lond); 2007 Feb; 2(1):23-39. PubMed ID: 17716188
[TBL] [Abstract][Full Text] [Related]
14. Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain.
Israel LL; Galstyan A; Holler E; Ljubimova JY
J Control Release; 2020 Apr; 320():45-62. PubMed ID: 31923537
[TBL] [Abstract][Full Text] [Related]
15. Size-Controlled Iron Oxide Nanoplatforms with Lipidoid-Stabilized Shells for Efficient Magnetic Resonance Imaging-Trackable Lymph Node Targeting and High-Capacity Biomolecule Display.
Clauson RM; Chen M; Scheetz LM; Berg B; Chertok B
ACS Appl Mater Interfaces; 2018 Jun; 10(24):20281-20295. PubMed ID: 29883088
[TBL] [Abstract][Full Text] [Related]
16. Monodisperse magnetic nanoparticles for theranostic applications.
Ho D; Sun X; Sun S
Acc Chem Res; 2011 Oct; 44(10):875-82. PubMed ID: 21661754
[TBL] [Abstract][Full Text] [Related]
17. Magnetic iron oxide nanoparticles as drug carriers: clinical relevance.
El-Boubbou K
Nanomedicine (Lond); 2018 Apr; 13(8):953-971. PubMed ID: 29376469
[TBL] [Abstract][Full Text] [Related]
18. Composite iron oxide-Prussian blue nanoparticles for magnetically guided T
Kale SS; Burga RA; Sweeney EE; Zun Z; Sze RW; Tuesca A; Subramony JA; Fernandes R
Int J Nanomedicine; 2017; 12():6413-6424. PubMed ID: 28919744
[TBL] [Abstract][Full Text] [Related]
19.
Buchholz O; Sajjamark K; Franke J; Wei H; Behrends A; Münkel C; Grüttner C; Levan P; von Elverfeldt D; Graeser M; Buzug T; Bär S; Hofmann UG
Theranostics; 2024; 14(1):324-340. PubMed ID: 38164157
[TBL] [Abstract][Full Text] [Related]
20. New Perspectives on Biomedical Applications of Iron Oxide Nanoparticles.
Magro M; Baratella D; Bonaiuto E; de A Roger J; Vianello F
Curr Med Chem; 2018 Feb; 25(4):540-555. PubMed ID: 28618993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
